ScripAlphabet ’s drug discovery spin-off Isomorphic has gained its first two big pharma partners in Novartis and Eli Lilly , signing deals which could eventually be worth a total of nearly $3bn. Isomorp
In VivoWhile Novartis AG and Roche Holding AG are the names that spring to mind when thinking of Switzerland, Swiss Biotech Association CEO Michael Altorfer argues that big pharma is just the tip of the
Medtech InsightSwiss data analytics company SOPHiA Genetics SA is integrating a new radiomics technology to enhance its artificial intelligence (AI) platform, used already for analyzing genomic data from liquid b
Medtech InsightWhile technology companies have long tapped into the potential of machine-learning and artificial intelligence to develop smarter, better and cheaper gadgets, a growing wave of health care companies a